Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
Cochrane Database of Systematic Reviews(2)
BMC Medical Research Methodology(1)
British Journal of Cancer(1)
Clinical and Translational Oncology(1)
European Journal of Cancer(1)
Chemotherapy for relapsed epithelial ovarian cancer
ArticleAbstract: This is the protocol for a review and there is no abstract. The objectives are as follows: We will aPalabras claves:Autores:Bonfill X., Ojeda B., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Roquéi Figuls M., Sola I.Fuentes:googlescopusBenefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
ArticleAbstract: Background: Although mammography screening is recommended in most European countries, the balance bePalabras claves:Autores:Alonso-Coello P., Canelo-Aybar C., Duffy S.W., Follmann M., Giorgi Rossi P., Gräwingholt A., Nadia G. Montero-Oleas, Posso M., Saz-Parkinson Z., Sola I.Fuentes:scopusEvidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST)
ArticleAbstract: Background: Gastrointestinal Stromal Tumours (GISTs) are the most common mesenchymal tumours. CurrenPalabras claves:Evidence mapping, Evidence synthesis, Gastrointestinal Stromal Tumours, Gist, Global evidence mappingAutores:Ballesteros M., Bonfill X., López-Pousa A., Nadia G. Montero-Oleas, Pardo-Hernandez H., Rada G., Sola I., Urrutia G.Fuentes:scopusEvidence mapping based on systematic reviews of therapeutic interventions for soft tissue sarcomas
ArticleAbstract: Purpose: Soft tissue sarcomas are a heterogeneous group of rare tumours of mesenchymal origin. EvidePalabras claves:Evidence mapping, Evidence synthesis, Global evidence mapping, Soft tissue sarcomasAutores:Ballesteros M., Bonfill X., López-Pousa A., Nadia G. Montero-Oleas, Pardo-Hernandez H., Rada G., Sola I., Urrutia G.Fuentes:scopusEfficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systematic reviews
ReviewAbstract: Background: Patients with advanced pancreatic cancer (PC) have a high risk of dying in the short orPalabras claves:antineoplastic agents, immunotherapy, Pancreatic neoplasms, Review literature as topicAutores:Acosta-Dighero R., Antequera A., Auladell-Rispau A., Bonfill X., Daniel Simancas-Racines, Dorantes-Romandía R., Gutiérrez M., Jesus Quintana M.A., Leache L., Meade A.G., Pérez-Bracchiglione J., Requeijo C., Ricardo Hidalgo-Ottolenghi, Rodríguez-Grijalva G., Saiz L.C., Salas-Gama K., Salazar J., Santero M., Sola I., Urrutia G.Fuentes:scopusImatinib for treating newly diagnosed chronic myeloid leukemia patients
ArticleAbstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To assessPalabras claves:Autores:Acevedo A.M., Anand V., Cardona A.F., Daniel Simancas-Racines, Gupta P., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Sola I.Fuentes:scopus